ANVS
Price
$3.40
Change
+$0.02 (+0.59%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
89.31M
124 days until earnings call
Intraday BUY SELL Signals
VYGR
Price
$4.17
Change
-$0.12 (-2.80%)
Updated
Nov 19, 04:59 PM (EDT)
Capitalization
231.57M
111 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ANVS vs VYGR

Header iconANVS vs VYGR Comparison
Open Charts ANVS vs VYGRBanner chart's image
Annovis Bio
Price$3.40
Change+$0.02 (+0.59%)
Volume$21.1K
Capitalization89.31M
Voyager Therapeutics
Price$4.17
Change-$0.12 (-2.80%)
Volume$6.84K
Capitalization231.57M
ANVS vs VYGR Comparison Chart in %
ANVS
Daily Signal:
Gain/Loss:
VYGR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
ANVS vs. VYGR commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANVS is a Hold and VYGR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 20, 2025
Stock price -- (ANVS: $3.37 vs. VYGR: $4.28)
Brand notoriety: ANVS and VYGR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANVS: 384% vs. VYGR: 69%
Market capitalization -- ANVS: $89.58M vs. VYGR: $231.57M
ANVS [@Biotechnology] is valued at $89.58M. VYGR’s [@Biotechnology] market capitalization is $231.57M. The market cap for tickers in the [@Biotechnology] industry ranges from $106.82B to $0. The average market capitalization across the [@Biotechnology] industry is $2.15B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANVS’s FA Score shows that 0 FA rating(s) are green whileVYGR’s FA Score has 1 green FA rating(s).

  • ANVS’s FA Score: 0 green, 5 red.
  • VYGR’s FA Score: 1 green, 4 red.
According to our system of comparison, VYGR is a better buy in the long-term than ANVS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANVS’s TA Score shows that 6 TA indicator(s) are bullish while VYGR’s TA Score has 5 bullish TA indicator(s).

  • ANVS’s TA Score: 6 bullish, 4 bearish.
  • VYGR’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ANVS is a better buy in the short-term than VYGR.

Price Growth

ANVS (@Biotechnology) experienced а +59.72% price change this week, while VYGR (@Biotechnology) price change was +0.59% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.17%. For the same industry, the average monthly price growth was -5.68%, and the average quarterly price growth was +64.91%.

Reported Earning Dates

ANVS is expected to report earnings on Mar 23, 2026.

VYGR is expected to report earnings on Mar 10, 2026.

Industries' Descriptions

@Biotechnology (-2.17% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VYGR($232M) has a higher market cap than ANVS($89.3M). VYGR YTD gains are higher at: -24.427 vs. ANVS (-33.002). ANVS has higher annual earnings (EBITDA): -23.68M vs. VYGR (-119.18M). VYGR has more cash in the bank: 43.9M vs. ANVS (17.1M). VYGR has higher revenues than ANVS: VYGR (42.6M) vs ANVS (0).
ANVSVYGRANVS / VYGR
Capitalization89.3M232M38%
EBITDA-23.68M-119.18M20%
Gain YTD-33.002-24.427135%
P/E RatioN/A6.00-
Revenue042.6M-
Total Cash17.1M43.9M39%
Total DebtN/A40.2M-
FUNDAMENTALS RATINGS
ANVS vs VYGR: Fundamental Ratings
ANVS
VYGR
OUTLOOK RATING
1..100
3569
VALUATION
overvalued / fair valued / undervalued
1..100
43
Fair valued
45
Fair valued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
10095
PRICE GROWTH RATING
1..100
3958
P/E GROWTH RATING
1..100
1008
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ANVS's Valuation (43) in the null industry is in the same range as VYGR (45) in the Biotechnology industry. This means that ANVS’s stock grew similarly to VYGR’s over the last 12 months.

ANVS's Profit vs Risk Rating (100) in the null industry is in the same range as VYGR (100) in the Biotechnology industry. This means that ANVS’s stock grew similarly to VYGR’s over the last 12 months.

VYGR's SMR Rating (95) in the Biotechnology industry is in the same range as ANVS (100) in the null industry. This means that VYGR’s stock grew similarly to ANVS’s over the last 12 months.

ANVS's Price Growth Rating (39) in the null industry is in the same range as VYGR (58) in the Biotechnology industry. This means that ANVS’s stock grew similarly to VYGR’s over the last 12 months.

VYGR's P/E Growth Rating (8) in the Biotechnology industry is significantly better than the same rating for ANVS (100) in the null industry. This means that VYGR’s stock grew significantly faster than ANVS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ANVSVYGR
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
86%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
82%
Declines
ODDS (%)
Bearish Trend 16 days ago
90%
Bearish Trend 6 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bullish Trend 2 days ago
78%
Aroon
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
ANVS
Daily Signal:
Gain/Loss:
VYGR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ASFT0.27N/A
N/A
AppSoft Technologies, Inc.
GSGTF0.19N/A
N/A
Gensight Biologics SA
LGDDF22.15N/A
N/A
LAGARDERE SA
KMAAF122.20N/A
N/A
Komax Holding Ag
NPPHY3.11-0.10
-2.96%
Nippon Paint Holdings Co., Ltd.

ANVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANVS has been loosely correlated with ADXN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ANVS jumps, then ADXN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANVS
1D Price
Change %
ANVS100%
+11.22%
ADXN - ANVS
43%
Loosely correlated
+6.67%
RXRX - ANVS
38%
Loosely correlated
+0.97%
MDGL - ANVS
36%
Loosely correlated
+1.01%
AMLX - ANVS
36%
Loosely correlated
-0.21%
VYGR - ANVS
36%
Loosely correlated
+4.26%
More